These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 38844980)
1. Deficiency of SDHC promotes metastasis by reprogramming fatty acid metabolism in colorectal cancer. Ding Z; Wei Y; Dai J; Pan C; Yang L; Li Q; Zhang Y; Yan Q; Wu C; Li A; Lan Z; Liu S; Wang X J Transl Med; 2024 Jun; 22(1):544. PubMed ID: 38844980 [TBL] [Abstract][Full Text] [Related]
2. PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism. Dai W; Xiang W; Han L; Yuan Z; Wang R; Ma Y; Yang Y; Cai S; Xu Y; Mo S; Li Q; Cai G Cancer Commun (Lond); 2022 Sep; 42(9):848-867. PubMed ID: 35904817 [TBL] [Abstract][Full Text] [Related]
3. Inhibitor of DNA binding 2 knockdown inhibits the growth and liver metastasis of colorectal cancer. Liu F; Chen S; Yu Y; Huang C; Chen H; Wang L; Zhang W; Wu J; Ye Y Gene; 2022 Apr; 819():146240. PubMed ID: 35114275 [TBL] [Abstract][Full Text] [Related]
4. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation. Ji B; Feng Y; Sun Y; Ji D; Qian W; Zhang Z; Wang Q; Zhang Y; Zhang C; Sun Y Oncol Rep; 2018 Oct; 40(4):1885-1896. PubMed ID: 30066935 [TBL] [Abstract][Full Text] [Related]
5. CPT1A-mediated fatty acid oxidation promotes colorectal cancer cell metastasis by inhibiting anoikis. Wang YN; Zeng ZL; Lu J; Wang Y; Liu ZX; He MM; Zhao Q; Wang ZX; Li T; Lu YX; Wu QN; Yu K; Wang F; Pu HY; Li B; Jia WH; Shi M; Xie D; Kang TB; Huang P; Ju HQ; Xu RH Oncogene; 2018 Nov; 37(46):6025-6040. PubMed ID: 29995871 [TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway. Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655 [TBL] [Abstract][Full Text] [Related]
7. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways. Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405 [TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA ABHD11-AS1 promotes colorectal cancer progression and invasion through targeting the integrin subunit alpha 5/focal adhesion kinase/phosphoinositide 3 kinase/Akt signaling pathway. Luo J; Jiang Y; Wu L; Zhuo D; Zhang S; Jiang X; Sun Y; Huang Y Aging (Albany NY); 2021 Aug; 13(16):20179-20191. PubMed ID: 34375304 [TBL] [Abstract][Full Text] [Related]
9. CHIP functions as an oncogene by promoting colorectal cancer metastasis via activation of MAPK and AKT signaling and suppression of E-cadherin. Xu J; Zhou J; Dai H; Liu F; Li W; Wang W; Guo F J Transl Med; 2018 Jun; 16(1):169. PubMed ID: 29921293 [TBL] [Abstract][Full Text] [Related]
10. Tumor suppressive effect of scavenger receptor class A member 5 overexpression in colorectal cancer by regulating PI3K/AKT/mTOR pathway. Li Y; Peng F; Tan X; Wang J; Xu Y Genes Genomics; 2021 Oct; 43(10):1189-1198. PubMed ID: 34417976 [TBL] [Abstract][Full Text] [Related]
11. CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARα pathways. Li J; Huang Q; Long X; Zhang J; Huang X; Aa J; Yang H; Chen Z; Xing J J Hepatol; 2015 Dec; 63(6):1378-89. PubMed ID: 26282231 [TBL] [Abstract][Full Text] [Related]
12. MYSM1 inhibits human colorectal cancer tumorigenesis by activating miR-200 family members/CDH1 and blocking PI3K/AKT signaling. Chen X; Wang W; Li Y; Huo Y; Zhang H; Feng F; Xi W; Zhang T; Gao J; Yang F; Chen S; Yang A; Wang T J Exp Clin Cancer Res; 2021 Oct; 40(1):341. PubMed ID: 34706761 [TBL] [Abstract][Full Text] [Related]
13. FUT2 promotes colorectal cancer metastasis by reprogramming fatty acid metabolism via YAP/TAZ signaling and SREBP-1. Dong C; Zhang Y; Zeng J; Chong S; Liu Y; Bian Z; Fan S; Chen X Commun Biol; 2024 Oct; 7(1):1297. PubMed ID: 39390072 [TBL] [Abstract][Full Text] [Related]
14. LINC01296/miR-26a/GALNT3 axis contributes to colorectal cancer progression by regulating O-glycosylated MUC1 via PI3K/AKT pathway. Liu B; Pan S; Xiao Y; Liu Q; Xu J; Jia L J Exp Clin Cancer Res; 2018 Dec; 37(1):316. PubMed ID: 30547804 [TBL] [Abstract][Full Text] [Related]
15. CircIL4R activates the PI3K/AKT signaling pathway via the miR-761/TRIM29/PHLPP1 axis and promotes proliferation and metastasis in colorectal cancer. Jiang T; Wang H; Liu L; Song H; Zhang Y; Wang J; Liu L; Xu T; Fan R; Xu Y; Wang S; Shi L; Zheng L; Wang R; Song J Mol Cancer; 2021 Dec; 20(1):167. PubMed ID: 34922544 [TBL] [Abstract][Full Text] [Related]
16. Oncogenic potential of BEST4 in colorectal cancer via activation of PI3K/Akt signaling. He XS; Ye WL; Zhang YJ; Yang XQ; Liu F; Wang JR; Ding XL; Yang Y; Zhang RN; Zhao YY; Bi HX; Guo LC; Gan WJ; Wu H Oncogene; 2022 Feb; 41(8):1166-1177. PubMed ID: 35058597 [TBL] [Abstract][Full Text] [Related]
17. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway. Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539 [TBL] [Abstract][Full Text] [Related]
18. Long Noncoding RNA PlncRNA-1 Promotes Colorectal Cancer Cell Progression by Regulating the PI3K/Akt Signaling Pathway. Song W; Mei JZ; Zhang M Oncol Res; 2018 Mar; 26(2):261-268. PubMed ID: 28835319 [TBL] [Abstract][Full Text] [Related]
19. Collagen facilitates the colorectal cancer stemness and metastasis through an integrin/PI3K/AKT/Snail signaling pathway. Wu X; Cai J; Zuo Z; Li J Biomed Pharmacother; 2019 Jun; 114():108708. PubMed ID: 30913493 [TBL] [Abstract][Full Text] [Related]
20. CircRNA_0000392 promotes colorectal cancer progression through the miR-193a-5p/PIK3R3/AKT axis. Xu H; Liu Y; Cheng P; Wang C; Liu Y; Zhou W; Xu Y; Ji G J Exp Clin Cancer Res; 2020 Dec; 39(1):283. PubMed ID: 33317596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]